Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn’s Disease
Aim. To compare the effectiveness of exclusive enteral nutrition (EEN) and infliximab (IFX) therapy in pediatric Crohn’s disease (CD). Methods. In a prospective study of children initiating EEN or infliximab therapy for CD, we compared clinical outcomes using the pediatric Crohn’s disease activity i...
Saved in:
Main Authors: | Youyou Luo, Jindan Yu, Jingan Lou, Youhong Fang, Jie Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/6595048 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of Pediatric Patients with Crohn’s Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission
by: Yao Lv, et al.
Published: (2022-01-01) -
Short-Term Efficacy of Exclusive Enteral Nutrition in Pediatric Crohn’s Disease: Practice in China
by: Youyou Luo, et al.
Published: (2015-01-01) -
Infliximab Combined with Enteral Nutrition for Managing Crohn’s Disease Complicated with Intestinal Fistulas
by: Xiao-Li Wu, et al.
Published: (2016-01-01) -
Enteral Nutrition in Crohn’s Disease: An Underused Therapy
by: S. Kansal, et al.
Published: (2013-01-01) -
Safety and Efficacy of Exclusive Enteral Nutrition for Percutaneously Undrainable Abdominal Abscesses in Crohn’s Disease
by: Yibin Zhu, et al.
Published: (2017-01-01)